BioSpace News Archive

Drug Development

RXi Pharmaceuticals Announces Positive NeuVaxTM (E75) Phase 2 Efficacy Results After 36 Months of Follow-Up

June 6, 2011
·
1 min read
Policy

IMPAX Laboratories, Inc. Provides an Update on Recent FDA Site Inspection

June 6, 2011
·
1 min read
BioMidwest

Myriad Genetics, Inc.'s PROLARIS(R) Test Shown to Significantly Predict Prostate Cancer Outcome From Needle Biopsy Tissue

June 6, 2011
·
1 min read
Drug Development

Threshold Pharmaceuticals, Inc. Provides Update on Continued Promising Data From a Phase 1/2 Clinical Trial of TH-302 at the American Society of Clinical Oncology Annual Meeting

June 6, 2011
·
1 min read
Biotech Bay

OXiGENE Complies With NASDAQ Listing Requirements

June 6, 2011
·
1 min read
BioMidwest

MedPro Imaging Adds 4D Transducer Repair Capabilities

June 6, 2011
·
2 min read
Drug Development

Endocyte, Inc.'s EC145 Meets Primary Endpoint in Phase 2 Study, Demonstrating 85 Percent (2.3 month) Improvement in Median Progression-Free Survival for Treatment of Platinum Resistant Ovarian Cancer

June 6, 2011
·
1 min read
Drug Development

OXiGENE Reports Encouraging Data From Phase 2 Trial of ZYBRESTAT(TM) in Non-small Cell Lung Cancer

June 6, 2011
·
1 min read
Drug Development

Infinity Pharmaceuticals Inc. Reports Results From Phase 1b Clinical Trial of IPI-926, an Oral Smoothened Antagonist, in Pancreatic Cancer at American Society of Clinical Oncology Meeting

June 6, 2011
·
1 min read
Genetown

AB SCIEX Release: New Technique to Revolutionize Proteomics Mass Spectrometry

June 6, 2011
·
1 min read